NCT02554539 Transciptomic Modification Induced by miRNAs in Endometrial Fluid Status COMPLETED Phase NA
NCT02553824 FDA Approved Medication to Reduce Binge Eating and/or Purging Status COMPLETED Phase PHASE1
NCT02533726 Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers Status COMPLETED Phase NA
NCT02530892 Correlation Between Oocyte and Embryo Mechanical Properties on Embryo Development and Clinical Pregnancy After In Vitro Fertilization Status COMPLETED Phase N/A
NCT02530606 Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer Status WITHDRAWN Phase NA
NCT02527564 Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder Status COMPLETED Phase PHASE4
NCT02519946 On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients Status COMPLETED Phase NA
NCT02512926 Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children Status COMPLETED Phase PHASE1
NCT02509416 Rapid Assessment of Trainee Endoscopy Skills (RATES) Study Two Status COMPLETED Phase N/A
NCT02503098 Optimizing a Smartphone Application for Individuals With Eating Disorders Status COMPLETED Phase NA
NCT02502162 Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome Status RECRUITING Phase NA
NCT02499978 Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated Toxicity Status WITHDRAWN Phase PHASE2/PHASE3
NCT02498912 Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02498444 Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation Status TERMINATED Phase NA
NCT02491788 Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers Status COMPLETED Phase PHASE4